569 related articles for article (PubMed ID: 32393321)
1. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
2. New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain.
Zhang JL; Si HF; Shang XF; Zhang XK; Li B; Zhou XZ; Zhang JY
Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():27-34. PubMed ID: 30599391
[TBL] [Abstract][Full Text] [Related]
3. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
Andrade RM; Chaparro JD; Capparelli E; Reed SL
PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
[TBL] [Abstract][Full Text] [Related]
4. Hydroxylamine and Carboxymethoxylamine Can Inhibit
Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
[No Abstract] [Full Text] [Related]
5. Two small-molecule inhibitors of
Hua QQ; Lin XJ; Xiang SP; Jiang LY; Cai JH; Sun JM; Tan F; Mou YN
Front Cell Infect Microbiol; 2023; 13():1145824. PubMed ID: 37077525
[TBL] [Abstract][Full Text] [Related]
6.
Adeyemi OS; Atolani O; Awakan OJ; Olaolu TD; Nwonuma CO; Alejolowo O; Otohinoyi DA; Rotimi D; Owolabi A; Batiha GE
Yale J Biol Med; 2019 Sep; 92(3):369-383. PubMed ID: 31543702
[TBL] [Abstract][Full Text] [Related]
7. Anti-Toxoplasma gondii effect of tylosin in vitro and in vivo.
Han RX; Jiang PC; Han B; Zhou HY; Wang YL; Guan JY; Liu ZR; He SY; Zhou CX
Parasit Vectors; 2024 Feb; 17(1):59. PubMed ID: 38341599
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
9. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.
da Silva LL; Portes Jde A; de Araújo MH; Silva JL; Rennó MN; Netto CD; da Silva AJ; Costa PR; De Souza W; Seabra SH; DaMatta RA
Parasitol Int; 2015 Dec; 64(6):622-31. PubMed ID: 26335616
[TBL] [Abstract][Full Text] [Related]
10. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
11. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
D'Angelo JG; Bordón C; Posner GH; Yolken R; Jones-Brando L
J Antimicrob Chemother; 2009 Jan; 63(1):146-50. PubMed ID: 18988681
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
15. Ketolide ABT-773 is active against Toxoplasma gondii.
Khan AA; Araujo FG; Craft JC; Remington JS
J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
[TBL] [Abstract][Full Text] [Related]
16. Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.
Han Y; Adeyemi OS; Kabir MHB; Kato K
Parasitol Res; 2020 May; 119(5):1675-1681. PubMed ID: 32236711
[TBL] [Abstract][Full Text] [Related]
17. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibit Toxoplasma gondii growth.
Saito H; Murata Y; Nonaka M; Kato K
J Vet Med Sci; 2020 Feb; 82(2):184-187. PubMed ID: 31904004
[TBL] [Abstract][Full Text] [Related]
18. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
19. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
20. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice.
Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
